Key result
Age ≥50 years is linked to ~5.8-fold higher odds of metabolic syndrome in MENA adults.
Why the study?
Metabolic syndrome is well studied in the United States population, but remains less characterized among Middle Eastern and North African adults residing in the U.S., partially due to historical misclassification within broader racial and ethnic categories.
What are the prevalence, component distribution, and associated risk factors of metabolic syndrome among Middle Eastern and North African adults residing in the United States?
Cross-Sectional (n=2,733)
Yes
What are the prevalence, component distribution, and associated risk factors of metabolic syndrome among Middle Eastern and North African adults residing in the United States?
Answers are grounded in this paper and cite their sources.
Nearly one in four US-based MENA adults in the All of Us cohort had metabolic syndrome—predominantly driven by dyslipidemia (low HDL and elevated triglycerides) and elevated blood pressure—supporting disaggregated cardiometabolic risk assessment and targeted prevention in this historically underrepresented population.
Background Metabolic syndrome (MetS) is well studied in the United States (U. S.) population, but remains less characterized among Middle Eastern and North African (MENA) adults residing in the U. S., partially due to their historical misclassification within broader racial and ethnic categories. Therefore, this study aimed to characterize prevalence, components distribution, and factors associated with MetS among MENA adults residing in the U. S. using data from the All of Us Research Program. Methods We conducted a cross-sectional study using Controlled Tier version 8 data from the All of Us Research Program. Participants were included in the study if they were aged ≥18 years, self-identified as MENA, had documented sex at birth, had at least one clinical encounter, and had data available on at least one of the MetS components, ensuring that participants had relevant clinical data available for MetS ascertainment. MetS was defined using criteria adapted from the National Cholesterol Education Program Adult Treatment Panel III, requiring presence of at least three of the five MetS components. Components distribution was examined in the overall MENA population, among MetS participants, and by birthplace, age, and sex subgroups. A multivariable stepwise logistic regression model was used to identify factors independently associated with MetS. Results Among 2,733 participants included in the study, 639 (23%) met the criteria for MetS. In the overall MENA population, MetS components varied significantly by birthplace, age, and sex. Among participants with MetS, low HDL cholesterol (92%), elevated triglycerides (91%), and elevated blood pressure (86%) were the most prevalent components. Factors significantly associated with MetS included age ≥50 years (odds ratio [OR] 5.78, 95% Confidence interval (CI) 4.54–7.36), sleep apnea (OR 4.34, 95% CI 2.99–6.30), liver disease (OR 2.99, 95% CI 2.15–4.16), anxiety (OR 2.57, 95% CI 1.97–3.36), obesity (OR 2.36, 95% CI 1.87–2.97), vitamin D deficiency (OR 2.24, 95% CI 1.68–2.99), hypothyroidism (OR 2.06, 95% CI 1.42–2.97), male sex (OR 1.79, 95% CI 1.42–2.25), unemployment (OR 1.55, 95% CI 1.24–1.95), and family history of diabetes (OR 1.51, 95% CI 1.16–1.96). Conclusion In the U. S.-based MENA cohort, nearly one-quarter of adults had MetS, with component patterns varying by birthplace, age, and sex. These findings support recognizing MENA adults as a distinct population in U. S. biomedical research and highlight the need for longitudinal and disaggregated studies to better understand cardiometabolic risk and inform targeted prevention strategies in this population.
No takes yet. Share an insight, caveat, or question.
Jafari et al. (2026) conducted a cross-sectional in Metabolic syndrome in Middle Eastern and North African (MENA) adults residing in the United States (n=2,733). Age ≥50 years and cardiometabolic/demographic risk factors among US-residing MENA adults vs. Age <50 years and absence of respective risk factors was evaluated on Prevalence of metabolic syndrome (defined by adapted NCEP ATP III criteria requiring ≥3 of 5 components) and association with age ≥50 years (OR 5.78, 95% CI 4.54-7.36, p=<0.0001). Among 2,733 MENA adults in the US, 23% had metabolic syndrome, with age ≥50 years and sleep apnea being the strongest associated factors.
Synapse has enriched 10 related papers. Consider them for comparative context: